Considering the intricate mechanisms related to SCA pathogenesis, we aimed to investigate in detail the effect of HU therapy on circulating monocytes subsets and on their ability to express TF as well as pro-inflammatory cytokines upon activation in SCA patients. The gene discussed is TF; the disease is autosomal dominant cerebellar ataxia.